NSE filing, NSE: HUBTOWN. Summary written from the filing by ALFA Finder's alert engine.
Hubtown Ltd: key numbers
- Share price
- ₹171.00
- Market cap
- ₹2,430 Cr
- Revenue (annual)
- ₹643.5 Cr
- Net profit (annual)
- ₹163.5 Cr
- P/E (TTM)
- 25.8×Sector 34.0×
- Promoter holding
- 33.17%+0.00% QoQ
- FII holding
- 1.48%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hubtown Ltd
All →Hubtown Board Meeting Date
Hubtown will hold a board meeting on 29 October 2026 to consider unaudited quarterly and half-year results. The intimation discloses no financial figures.
Hubtown Acquisition Worth ₹3.26 Cr
Hubtown Limited is subscribing to shares in its subsidiary, Rare Townships Private Limited, for a total consideration of ₹3.26 Crore, increasing its stake to 75.24%.
- Value
- ₹3.26 Cr
Hubtown Acquisition Worth ₹36.78 Cr
Hubtown Limited invested Rs. 36.78 Crore in its subsidiary, Rare Townships Private Limited, through a rights issue subscription. This increases its stake to 74.65%.
- Value
- ₹36.78 Cr
Hubtown Annual General Meeting
Hubtown Ltd held its 38th AGM on September 18, 2026. The meeting covered standard business, including approval for raising FCCBs up to US$ 150 Million.
Hubtown Annual General Meeting
Hubtown Limited has issued the notice for its 38th Annual General Meeting scheduled for September 18, 2026. The agenda includes financial adoption and various special business proposals.
Hubtown Annual Report
Hubtown Limited filed its 38th Annual Report for FY 2025-26, detailing operational highlights, portfolio projects, and corporate restructuring strategies. The report summarizes consolidated financial performance.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.